sildenafil-citrate has been researched along with Tinnitus* in 3 studies
3 other study(ies) available for sildenafil-citrate and Tinnitus
Article | Year |
---|---|
Therapeutic effect of sildenafil on blast-induced tinnitus and auditory impairment.
Blast-induced tinnitus, along with associated auditory impairment and traumatic brain injury, is a primary concern facing military service members. To search for treatment, we investigated the therapeutic effects of sildenafil, a phosphodiesterase-5 inhibitor, given its vasodilatory effects and evidence suggesting its beneficial effects on noise-induced hearing loss. Rats were subjected to three consecutive blast exposures at 22 psi and were monitored for tinnitus using a gap-detection acoustic startle reflex paradigm. Hearing thresholds and detection were tested using auditory brainstem responses and prepulse inhibition, respectively. Blasted rats were either treated with sildenafil or tap water following blast exposure, while age-matched sham control rats were treated with sildenafil and no blast exposure. Our results showed that sildenafil did not effectively prevent acute tinnitus onset and hearing impairment. Instead, sildenafil significantly suppressed high-frequency tinnitus from 3 to 6 weeks after blast exposure and reduced hearing impairment during the first week after blast exposure. Complex results were observed in the startle force data, where sildenafil-treated rats displayed significantly reduced startle force compared to the untreated blasted group, suggesting possible mitigation of traumatic brain injury and suppression of hyperacusis-like percepts. Taken together, sildenafil showed a therapeutic effect on blast-induced tinnitus and audiological impairment in a time-dependent manner. Other regimens such as higher dosage prior to blast exposure and combination with other treatments deserve further investigation to optimize the therapeutic effects. Topics: Acoustic Stimulation; Animals; Auditory Threshold; Blast Injuries; Evoked Potentials, Auditory, Brain Stem; Functional Laterality; Hearing Loss; Male; Motor Activity; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Prepulse Inhibition; Purines; Rats, Sprague-Dawley; Reflex, Startle; Sildenafil Citrate; Sulfones; Time Factors; Tinnitus | 2014 |
Vestibular symptoms as a complication of sildenafil: a case report.
Potential vasodilator side effects of sildenafil such as headache, flushing, dyspepsia, heartburn, nasal congestion, dizziness and visual changes have been frequently observed. We report a 79-year-old man who developed severe vestibular neuritis-like symptoms (horizontal nystagmus with rotatory components and vomiting) two hours after taking 50 mg sildenafil. Additionally, the patient complained of tinnitus in both ears. Internal and neurological examination revealed no pathological findings and the patient had no history of cardiovascular disease. The symptoms lasted for 24 hours and then resolved completely. All of the patient's complaints indicated a drug-related phenomenon. This drug related adverse reaction should be included in the long list of potential side effects of sildenafil. Topics: Adverse Drug Reaction Reporting Systems; Aged; Erectile Dysfunction; Humans; Male; Neurologic Examination; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Tinnitus; Vasodilator Agents; Vestibular Neuronitis | 2002 |
Sildenafil (Viagra) and endolymphatic hydrops.
Topics: Endolymphatic Hydrops; Female; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tinnitus | 2000 |